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DESCRIPTION
An 89-year-old woman was referred to the accident
and emergency department with droopy eyelids. The
onset of symptoms coincided with the initiation of
clarithromycin prescribed for a respiratory tract
infection. She was also reported to have a change in
the quality of her voice and was choking on ﬂuids.
On examination she had bilateral ptosis and complete
ophthalmoplegia. Pupils were unreactive but the
patient had undergone bilateral cataract surgery in
the past. Her speech was dysarthric. Examination of
the extremities revealed mild weakness proximally
with no deﬁnite fatigability and generalised areﬂexia.
Sensory examination was normal. Routine bloods,
CTof the brain and lumbar puncture were unreveal-
ing. A differential diagnosis of the Miller-Fisher
variant1 of Guillain-Barré syndrome and myasthenia
gravis, possibly triggered by the use of macrolide anti-
biotics,2 was made. There was nothing to suggest a
diagnosis of botulism. The patient was treated with
intravenous immunoglobulins. No improvement was
seen with a trial of low dose pyridosytigmine and
repetitive nerve stimulation showed no signiﬁcant
decremental response. Acetylcholine receptor anti-
bodies were negative, but anti-GQ1b antibodies were
strongly positive at 361% (normal range <30%) con-
ﬁrming a diagnosis of Miller-Fisher syndrome. The
patient recovered fully and returned to baseline con-
dition within 8 weeks (video 1).
Learning points
▸ Miller-Fisher syndrome accounts for
approximately 5% of Guillain-Barré syndrome
and can present with ptosis and complete
ophthalmoplegia.
▸ Acute ophthalmoplegia in Miller-Fisher
syndrome is highly associated with serum IgG
antibody against GQ1b.
▸ Miller-Fisher syndrome is potentially fully
reversible with treatment even in older age
groups.
Correction notice This article has been corrected since it was
published Online on 18 March 2013. The missing video has now
been included.
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Video 1 Patient with bilateral ptosis and
opthalmoplegia.
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